UNSPSC 51385401: Cinchophen

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C16H11NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 39Y533Z02M, chemically known as 4-quinolinecarboxylic acid, 2-phenyl- (9ci) but generally known as cinchophen, which bears US NIH Compound Identifier 8593. European Medicines Agency schedules Cinchophen in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06288MIG. The term CINCHOPHEN is an International Non-Proprietary Name.

UNSPSC 51385401 Cinchophen, a Commodity code, does not align with the actual work being solicited under this code by state and local governments. The single recent opportunity in the source is Seminole County, Florida's procurement of naloxone and drug deactivation systems for community health support, which falls outside the scope of cinchophen (a uricosuric drug used in gout treatment). The mismatch suggests either a data-entry error in how the opportunity was tagged or a fundamental misclassification in the state and local procurement system. No additional opportunities under this code appear in the source.

Activity under UNSPSC 51385401 remains opaque based on available recent procurement records. Without a coherent set of opportunities aligned to the code's stated pharmaceutical category, no reliable signal exists regarding issuing-body types, geographic concentration, or market demand. Business development professionals should verify whether cinchophen represents an active procurement category within state and local health systems or whether the code is primarily a taxonomy placeholder with minimal real-world sourcing activity.